KCG
AEGR

Knight Capital Group’s Aegerion Pharmaceuticals AEGR Stock Holding History

Knight Capital Group’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$528K Buy
+8,339
New +$443K 0.01% 1657

Other funds holding AEGR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Knight Capital Group's AEGR Position: Q2 2013 in Review

Knight Capital Group opened a new position in Aegerion Pharmaceuticals (AEGR) in Q2 2013: 8,339 shares worth $528K. The stake represents 0.01% of the portfolio and ranks #1657 among its holdings.

145 funds tracked by Wall St. Rank hold AEGR as of Q2 2013.

  • Knight Capital Group held 8,339 shares of Aegerion Pharmaceuticals worth $528K as of Q2 2013.
  • Aegerion Pharmaceuticals was a new Knight Capital Group position in Q2 2013.
  • Aegerion Pharmaceuticals made up 0.01% of Knight Capital Group's portfolio in Q2 2013, its #1657 holding.
  • 145 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.